Form 4: Accuray SVP, Chief Commercial Officer Reports Routine Insider Stock Transactions

Accuray Inc.'s SVP, Chief Commercial Officer, Sandeep Chalke, reported the disposition of 35,123 shares for tax obligations and the acquisition of 5,000 shares through the Employee Stock Purchase Plan.

Summary

• Sandeep Chalke, SVP, Chief Commercial Officer of Accuray Inc. (ARAY), reported stock transactions on May 31, 2025.
• A total of 35,123 shares of Common Stock were disposed of at a price of $1.55 per share.
• This disposition was a non-discretionary event, as the shares were withheld by Accuray Inc. to satisfy tax withholding and remittance obligations in connection with the net settlement of Restricted Stock Units (RSUs).
• Following these reported transactions, Sandeep Chalke beneficially owns 471,469 shares of Accuray Inc. Common Stock.
• The reported beneficial ownership includes 2,500 shares acquired on November 29, 2024, and an additional 2,500 shares acquired on May 30, 2025, under the Accuray Employee Stock Purchase Plan (ESPP), which are exempt under Rule 16b-3(c).

Sentiment

Score: 6

Explanation: The sentiment is mildly positive. The disposition of shares was for tax purposes, which is a neutral event. The acquisition of shares through the ESPP indicates continued insider investment, which is generally viewed positively as it aligns management's interests with shareholders.

Positives

• Sandeep Chalke acquired a total of 5,000 shares through the Accuray Employee Stock Purchase Plan (ESPP) on November 29, 2024, and May 30, 2025, indicating continued insider investment and alignment with shareholder interests.

Negatives

• The disposition of 35,123 shares was solely for tax withholding purposes related to RSU vesting, which is a standard and expected event for equity compensation and does not reflect a discretionary sale by the insider.

Risks

• No specific risks related to the company's operations, financial health, or future prospects are mentioned in this Form 4 filing.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding Accuray Inc.'s future performance or strategic outlook.

Industry Context

This Form 4 filing is a routine regulatory disclosure of an insider stock transaction for Accuray Inc., a company operating in the medical device sector, specifically focused on radiation therapy systems. Such filings are standard compliance requirements and do not typically offer insights into broader industry trends, competitive landscapes, or market dynamics.

Related Party Transactions

• The transactions involve an officer of the company (Sandeep Chalke) and the company itself (Accuray Inc.) for tax withholding related to RSU vesting and acquisitions through the Employee Stock Purchase Plan. These are standard related-party transactions for executive compensation and employee benefit plans.

Stakeholder Impact

• Shareholders: The routine nature of the tax-related disposition has minimal direct impact. The ESPP acquisitions by an executive can be seen as a minor positive signal of continued insider alignment.
• Employees: The ESPP acquisitions highlight the availability and utilization of employee stock purchase plans, which are a benefit for employees.

Key Dates

Recommendation

Keywords

Accuray Inc., ARAY, Sandeep Chalke, Form 4, insider trading, stock transaction, RSU, Restricted Stock Units, ESPP, Employee Stock Purchase Plan, beneficial ownership, tax withholding